Comparative Efficacy of Elinzanetant Versus Other Non‐Hormonal Pharmaceutical Therapies for the Treatment of Moderate‐to‐Severe Vasomotor Symptoms Associated With Menopause: A Network Meta‐Analysis
In this indirect comparison, elinzanetant showed superior or comparable efficacy to NKT or nHT in reducing the frequency and severity of VMS, along with improving sleep disturbances, supporting its role in VMS management.
Authors
- Andromachi Giannopoulou
- Beata Smela (ORCID: https://orcid.org/0000-0003-4896-9083)
- K.R. Bolling
- L.P. Shulman (ORCID: https://orcid.org/0000-0002-4781-0866)
- Vikram Sinai Talaulikar (ORCID: https://orcid.org/0000-0002-2058-722X)
- Elżbieta Olewińska (ORCID: https://orcid.org/0009-0001-6014-1193)
- Klaudia Kolonko
- Jenifer Sassarini
- Piotr Wojciechowski
Institutions
- Northwestern University (US)
- University School of Physical Education in Kraków (PL)
- NHS Greater Glasgow and Clyde (GB)
- Bayer (Switzerland) (CH)
- Tampa Bay Research Institute (US)
- University College London (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- BJOG An International Journal of Obstetrics & Gynaecology
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1111/1471-0528.70213
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00